Purchase Order 36C25525P0127

Award Date 1/7/25
Potential Completion Date 4/7/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company (BD), by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA). The $15,318.00 contract is for the delivery of vascular stents, with a period of performance ending on March 31, 2024. C.R. Bard is a manufacturer of various medical devices and supplies, including vascular stents, surgical implants, catheters, and temperature management...
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,660.80, is for the delivery of three vascular stents to be used in the VA's healthcare facilities. The contract has an ultimate completion date of March 31, 2025 and was awarded on December 3, 2024. Bard is a for-profit medical device manufacturer that has a long-standing...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of two vascular stents, with a ceiling value of $10,162.79 and a period of performance ending on March 31, 2025. The contract does not have a set-aside designation, indicating that Bard competed for the...
This is a firm-fixed-price purchase order worth $18,731.00, awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard. The contract is for the procurement of 3 E-Luminexx vascular stents and 2 LifeStream covered stents, which are medical devices used in vascular procedures. This award was made in accordance with 38 USC 8123 and 38 CFR 17.3240, which provide authority for the VA to purchase prosthetic...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the Department of Veterans Affairs (VA), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of vascular stents (x3) for $22,992.20, with a completion date of December 31, 2024. Bard is a for-profit organization and manufacturer of medical devices that has received numerous federal contract awards...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,891.00, is for the delivery of three (3) vascular stents to support the VA's healthcare operations. The contract has an ultimate completion date of December 31, 2024 and does not utilize any set-aside designations. Bard is a manufacturer of a wide range of medical devices and...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order valued at $11,218.90 to C.R. Bard, Inc. (Bard) for the provision of vascular stents. Bard, a subsidiary of Becton, Dickinson and Company (BD), is a manufacturer of medical devices and supplies that has a longstanding history of providing products to federal agencies, including the VA and Department of Defense. The contract has an ultimate completion date of September 30, 2024 and was awarded on March 13, 2024. This...
This is a firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc. (operating as Bard), a subsidiary of Becton, Dickinson and Company (BD). The $25,405.60 contract is for the supply of vascular stents to support healthcare delivery across the VA's integrated service networks. Bard, a major medical device manufacturer, has a long history of federal contract awards from the VA, Department of Defense (DoD), and other agencies for a range of products...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order to C.R. Bard, Inc., operating as Bard, for the supply of vascular stents. The contract has a ceiling value of $14,891.80 and a completion date of September 30, 2024. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology firm specializing in various medical devices, instruments, and supplies. Bard has a long history of providing healthcare products to federal agencies, including the...
This federal contract award, valued at $11,299.89, was issued by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of the medical technology manufacturer Becton, Dickinson and Company (BD). The contract is for the delivery of three vascular stents, with a performance period ending on March 31, 2025. This contract award, structured as a firm-fixed-price purchase order, does not utilize...

This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard. The contract, valued at $14,946.13, is for the delivery of three (3) vascular stents to support the VA's medical device needs. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer, and has been providing a range of medical devices and supplies to the VA and Department of Defense (DoD) through federal contract awards since 2002. This award is not associated with any set-aside designation, indicating that Bard competed for the contract based on its capabilities and product offerings. The contract has an ultimate completion date of April 7, 2025.

Generated 1/9/25, 9:05 AM